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Abstract 
Purpose: To evaluate the antioxidant and antihyperlipidemic activities of the methanol extract of aerial 
part of Crassocephalum crepidioides (Asteraceae) Benth. S. Moore. 
Methods: The methanol extract of Crassocephalum crepidioides was prepared by organic solvent 
extraction (Maceration) and assessed for in vitro antioxidant activity using various methods, namely, 
2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay, total phenol and flavonoid content and 
reducing capacity. The extract was also evaluated for antihyperlipidemic activity in high-fat diet and 
triton WR-100 (iso-octyl polyoxyethylene phenol)-induced hyperlipidemic albino rats by evaluating 
serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL-c), triglycerides (TG), very low 
density lipoprotein cholesterol (VLDL-c), low-density lipoprotein cholesterol (LDL-c) level and 
atherogenic index (AI). 
Results: The plant extract showed significant antioxidant activity in a dose-dependent manner. In high-
fat diet hyperlipedemic rats, the extract significantly reduced (p < 0.01 or 0.001) serum TC, TG, LDL-c 
and VLDL-c levels, but significantly increased (p < 0.05) serum HDL-c level. In triton-induced 
hyperlipidemic rats, the extract significantly reduced (p < 0.05, p < 0.01, p < 0.001) serum TC, TG, LDL-
c, VLDL-c levels but significantly increased (p < 0.05) serum HDL-c level. The extract showed significant 
reduction (p < 0.01) in AI at 300 mg /kg/day dose in both high fat-induced (1.70 ± 0.25) and triton-
induced (1.5 ± 0.17) hyperlipidemic albino rats.  
Conclusion: Based on these findings, the extract of Crassocephalum crepidioides aids in lowering 
hyperlipidemia in rats. This is probably due to its antioxidant activity.  
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Reactive oxygen species (ROS), such as 
superoxide anions, hydrogen peroxide, and 
hydroxyl, nitric oxide and peroxynitrite radicals, 
play an important role in oxidative stress related 
to  pathogenesis of various important diseases 
[1]. The body possesses several defense 
systems comprising enzymes and radical 
scavengers [2]. Some of them constitute the 
repair systems for biomolecules that are 
damaged by the attack of free radicals [3]. 
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Antioxidants from plant materials terminate the 
action of free radicals, thereby protecting the 
body from various diseases [4]. 
 
Endothelial cells, smooth muscle cells, and 
macrophages are the sources of oxidants for the 
oxidative modification of phospholipids. Oxidized-
LDL can damage endothelial cells and induce the 
expression of adhesion molecules such as P-
selectin and chemotactic factors such as 
monocyte chemoattractant protein-1 and 
macrophage colony stimulating factor. These 
processes lead to the tethering, activation, and 
attachment of monocytes and T- lymphocytes to 
the endothelial cells [5,6]. There is evidence that 
macrophages in atherosclerotic lesions express 
myeloperoxidase that yields a unique pattern of 
protein oxidation products. Myeloperoxidase is 
also pinpointed as a pathway that promotes LDL 
oxidation [7]. Natural products with antioxidant 
potential have been proposed as effective in the 
treatment of metabolic syndrome like insulin 
resistance, diabetes, obesity, altered lipid profile, 
and hypertension [8-10] 
 
The genus Crassocephalum is in the family 
Asteraceae (Compositae) in the major group 
Angiosperms (Flowering plants). Its fleshy, 
mucilaginous leaves and stems are commonly 
eaten, and many parts of the plant have 
medicinal uses [11]. Moreover, Crassocephalum 
crepidioides has been reported as effective in the 
treatment of indigestion, stomach ache, epilepsy, 
sleeping sickness and swollen lips, and also 
possesses antitumor activity associated with 
nitric oxide production [12]. It was also found that 
it is a potent antioxidant, and protects against 
hepatotoxicity [13]. Despite the long traditional 
use of this plant in the treatment of various 
pathological conditions, no systemic 
phytochemical and pharmacological works have 
been carried out on this potential medicinal plant. 
Therefore, the aim of the present study is to 
identify antioxidants and anihyperlipidemic 







Crassocephalum crepidioides was collected from 
Fatickchari, Chittagong in October 2013. 
Taxonomic identification of this plant was made 
by Dr. Shaikh Bokhtear Uddin, Associate 
Professor, Department of Botany, University of 
Chittagong (CU), Bangladesh. A voucher 
specimen (no. SUS 5396) was deposited in the 
herbarium of Department of Botany, University of 
Chittagong for preservation.  
 
Preparation of extracts 
 
The plant was washed, shade dried and 
powdered in a heavy-duty Willy mill (Bells India 
Ltd.), and then 500 g of dried powder was 
soaked in 2500 mL of methanol. After 15 days, 
the whole mixture was filtered through cotton 
wool and the filtrate was concentrated under 
reduced pressure using a rotatory evaporator 
method. The yield of extract was 43 %. The 
extract was stored in the refrigerator at 4 oC until 
further use. The extract was dissolved in 1 % 
carboxyl-methyl cellulose used for the animal 
studies [14]. 
 
Preliminary phytochemical screening of 
methanolic plant extract 
 
The methanol extract of Crassocephalum 
crepidioides was subjected to preliminary 
phytochemical screening for the presence of 
alkaloids, glycosides, cardiac glycosides, 
steroids, coumarin, tannins, flavonoids, saponins 
and reducing sugar [15,16]. The color intensity or 
the precipitate formation was used as analytical 
responses to these tests. 
 
Experimental animal  
 
Wistar albino rats of either sex, aged 8 - 10 
weeks, weighing 120 - 250 g each obtained from 
the animal house of Jahangirnagar University 
were used for the experiment. They were kept in 
clean and dry polypropylene cages with 12 h 
light, dark cycle at 25 ± 2 °C and 45 – 55 % 
relative humidity in the animal house. The rats 
were fed with a standard laboratory diet and 
water ad libitum. Food was withdrawn 12 h prior 
to and during the experiment. As these animals 
are very sensitive to environmental changes, 
they are kept before the test for at least 3 to 4 
days in the environment where the experiment 
will take place [17]. The protocol used in this 
study in the rat as an animal model for diabetic 
and antihyperlipidemic research was carried out 
based on the guidelines of the Institutional 
Animal Ethics Committee (IAEC). 
 
Acute toxicity studies  
 
Crassocephalum crepidioides in the dose range 
of 100 - 2500 mg/kg was dissolved in 1 % 
carboxyl-methyl cellulose and administered 
orally, each group comprised of five rats. 
Mortality was observed after 72 h. Acute toxicity 
was determined according to the method of 
Litchfield and Wilcoxon [18]. 
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Determination of DPPH scavenging activity 
 
The assay was conducted on the basis of 
scavenging activity of the stable DPPH free 
radical following a previously described method 
with some minor modifications [19,20]. To 1 ml of 
the sample (5, 10, 20, 30, 40, and 50 μg/mL) was 
added 3 ml of a 0.1 mmol/L methanol solution of 
DPPH. The absorbance of all the samples was 
determined at 517 nm (Shimmadzu-1800, Japan) 
after an incubation period of 30 min. Inhibition of 
DPPH (D) was determined according to Eq 1.  
 
D (%) = {(Ac – As)/Ac}100 …………………. (1) 
 
where Ac and As are the absorbance of control 
and test samples, respectively. 
 
Evaluation of total phenolic content  
 
The total phenolic content of the extract of 
Crassocephalum crepidioides was determined 
using the Folin-Ciocalteu method [21]. The 
extract was oxidized with Folin-Ciocalteu reagent 
and was neutralized with sodium carbonate. The 
absorbance of the resulting blue color solution 
was measured at 760 nm after 60 min using 
gallic acid (GA) as standard. Total phenolic 
content was expressed as mg GA equivalent/gm 
of extract. 
 
Assessment of total flavonoid content 
 
The flavonoid content was determined using a 
method described by Karunakaran et al with 
quercetin as reference standard [22]. The extract 
(1 mg) was mixed with 1 ml of aluminium 
trichloride in ethanol (20 mg/mL), and then one 
drop of acetic acid was added. The mixture was 
then diluted up to 25 mL with ethanol. The 
absorbance at 415 nm was read after 40 min. 
The absorbance of blank samples and standard 
quercetin solution (0.5 mg/mL) in methanol was 
measured under the same condition. 
 
Reducing power assay 
 
The assay was conducted according to a 
previously reported method [23,24]. According to 
this method, the reduction of Fe3+ to Fe2+ was 
determined by measuring absorbance of Pearl's 
Prussian blue complex. This method is based on 
the reduction of (Fe3+) ferricyanide in 
stoichiometric excess relative to the antioxidants. 
To different concentrations of the extracts (125, 
250, 500 and 1000 μg/mL) were added 2.5 mL of 
0.2 M phosphate buffer (pH 6.6) and 2.5 mL of 1 
% potassium ferricyanide [K3Fe(CN)6]. The 
mixture was incubated at 50 °C for 20 min and 
2.5 mL of 10 % trichloroacetic acid was added to 
the mixture and centrifuged at 3000 rpm for 
10 min. The upper layer (2.5 mL) was added to 
(2.5 mL) distilled water and FeCl3 (0.5 mL, 0.1 
%), and the absorbance was measured at 
700 nm. 
 
High fat induced hyperlipidemia model  
 
The method of Blank et al [25] with modification 
was used to produce high fat diet induced 
hyperlipidemia. Normal food pellets were 
crushed into small pieces using a mortar and 
pestle and then ground into a fine powder in a 
mixer grinder (Philips HL 7720). The other 
ingredients i.e. cholesterol 2 %, cholic acid 1 %, 
sucrose 40 %, and coconut oil 10 % were added 
in the mixer grinder to make small balls of feed 
and later this was stored in self-sealing plastic 
cover in refrigerator at 2 to 8 °C.  
 
The feed for normal group was prepared similarly 
by grinding only the normal food pellets and then 
mixing with water without the other excipients 
[26-28]. This of feed was done once in three 
days for all the animals. The animals were fed 
with the high fat diet for 30 days and the serum 
blood cholesterol level was routinely checked. 
 
Experimental design for high fat induced 
hyperlipidemic rats 
 
Wistar rats weighing 150-180 g were divided into 
5 groups of 5 animals each. 
 
Group 1: Served as normal control and were 
given only vehicle (distilled water) 
 
Group 2: Received high fat diet served as 
hyperlipidemic control (positive control) 
 
Group 3: Received 10 mg/kg/day atorvastatin 
served as standard 
 
Group 4: Received 150 mg/kg/day plant extract 
 
Group 5: Received 300 mg/kg/day plant extract 
 
After treatment for 14 days with the test sample, 
on the 15th day rats were kept fasting and blood 
was collected by retro orbital sinus puncture, 
under mild ether anesthesia. The collected 
samples were centrifuged for 30 min at 2000 rpm 
and serum sample so collected were used for 
various biochemical tests. 
 
Triton X-100-induced hyperlipidemia model 
 
Twenty five Wistar rats were randomly divided 
into 5 groups of 5 each. The first group was 
given a standard pellet diet, water and orally 
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administered with 5 % carboxy methyl cellulose 
(CMC). Groups 2, 3, 4 and 5 were injected (i.p.) 
with 10 % aqueous solution of Triton X-100 
mg/kg body weight. After 72 h of triton injection, 
the second group received a daily dose of 5 % 
CMC (p.o.) for 7 days, groups 4 and 5 were 
received a daily dose of plant extract 150 mg/kg 
and 300 mg/kg in 5 % CMC (p.o) for 7 days and 
group 3 was administered with the standard 
atorvastatin 10 mg/kg (p.o) for 7 days. Food was 
withdraw 10 h prior to blood sampling.  
 
Experimental design for triton X-100 induced 
hyperlipidemic rats  
 
Group 1: Administered vehicle and serve as 
normal control. 
 
Group 2: Administered Triton X (TR) and served 
as hyperlipidipic control (positive control) 
 
Group 3: Administered atorvastatin (10 
mg/kg/day, p.o.) 
 
Group 4: Administered plant extract (150 
mg/kg/day, p.o.) 
 
Group 5: Administered plant extract (300 
mg/kg/day, p.o.) 
 
On the 8th day, blood was collected from rates 
by retro-orbital sinus puncture, under ether 
anesthesia. The collected samples were 
centrifuged for 15 min at 2500 rpm. Thereafter, 
serum samples were collected and determined 
TC, TG and HDL-c with the appropriate kits 
(Randox Laboratories Limited, Crumlin, UK). 
VLDL-c and LDL-c were calculated as in 
Friedewald’s relationships (Eqs 2 and 3) [30]. 
 
VLDL-c = (TG)/5 ………….…………………. (2) 
 
LDL-c = TC-(HDL-c+VLDL-c) ……………… (3) 
Atherogenic index was calculated as in Eq 4 
(Schulpis’ equation) [31]. 
 
Atherogenic index (AI) = (TC – HDL-c)/HDL-c …… (4) 
 
Statistical data analysis 
 
All the data are expressed as mean ± standard 
deviation (SD) and were analyzed by one-way 
analysis of variance (ANOVA) followed by 
Dunnett’s test using SPSS software (version16). 





The qualitative phytochemical profile of the 
extract shows the presence of alkaloids, 
glycosides, tannins, flavonoids, saponins and 




The plant extract was safe up to a dose of 2500 
mg/kg of body weight. The behavior of the 
animals was observed for the first 8 h, then at an 
interval of every 8 h during next 72 h. The extract 
did not produce a significant change in animal 
behavior or mortality. 
 
DPPH scavenging activity 
 
The DPPH radical scavenging activity of 
methanol extract of Crassocephalum 
crepidioides was found to increase with 
increasing concentration of the extracts (Figure 
1). The DPPH radical contains an odd electron, 
which is responsible for absorbance at 515-517 
nm and also for a visible deep purple color. 
 
The IC50 value of the extract was 130.320 µg/mL 
while the IC50 of ascorbic acid was 11.24 µg/mL. 
These results indicate significant antioxidant 
activity of methanol extract of Crassocephalum 
crepidioides. 
 
Table 1: Qualitative phytochemical profile of methanol extract of Crassocephalum crepidioides 
 
Examination Test performed Inference 
Alkaloids Wagner`s test +++ 
Glycosides General test +++ 
Cardiac glycosides Keller-killiani test ± 
Steroids Salkowski`s test ± 
Coumarin General ++ 
Tannins Ferric chloride test ++ 
Flavonoids Conc. HCl & alcoholic test ++ 
Saponins Shake test (aq. solution) + 
Reducing sugar Fehling`s test ++ 
Key: + = weak intensity reaction, ++ = medium intensity reaction, +++ = strong intensity reaction, 
± = present/absent, Conc. = concentrated, aq = Aqueous 
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Figure 1: DPPH Scavenging activity of methanol 
extract of Crassocephalum crepidioides compared 
with ascorbic acid as standard. Key: ■ = Ascorbic 
acid, ● = Methanol extract 
 
Total phenol and flavonoid content 
Total phenol and flavonoid content of methanol 
extract of the aerial part of Crassocephalum 
crepidioides were expressed in gallic acid 
quercetin equivalents respectively. The phenolic 
content of the extract under this investigation 
correlates with their antioxidant activity (128.016 
± 0.056 mg GAE/g). Flavonoid content of the 
extract was also found to be significant 
compared to standard (168.33 ± 0.061 mg QE/g).  
 




Figure 2: Reducing power of methanol extract of 
Crassocephalum crepidioides compared with ascorbic 
acid as standard. Key: ■ = Ascorbic acid, ● = 
Methanol extract 
The methanol extract of Crassocephalum 
crepidioides showed reductive capabilities 
compared to ascorbic acid, which was 
determined using the potassium ferricyanide 
reduction method. The reducing power of the 
extracts was found to increase with increasing 
concentration (Fig 2). 
 
Effect of Crassocephalum crepidioides 
extract on lipid profile  
 
In the high fat diet-induced hyperlipidemia model, 
oral administration of methanol extract of 
Crassocephalum crepidioides (150 mg/kg and 
300 mg/kg, p.o.) significantly reduced the serum 
TC, TG, LDL-c, VLDL-c levels but significantly 
increased serum HDL-c level compared with a 
positive control group (Table 2).  
 
Serum lipid parameters were significantly 
reduced (p < 0.05) by fourteen days treatment 
with Crassocephalum crepidioides at dose levels 
of 150 and 300 mg/kg, when compared with the 
positive control group. The 300 mg/kg showed 
significant (p < 0.01) antihyperlipidemic activity 
compared with the positive control group and all 
treated groups showed significant reduction (p < 
0.05) in AI compared to positive control group. 
 
Effect of methanol extract of Crassocephalum 
crepidioides on lipid profile in Triton X-100-
induced hyperlipidemia model 
 
In triton X-100 induced hyperlipidemia model , 
oral administration of methanol extract of 
Crassocephalum crepidioides (150 mg/kg and 
300 mg/kg, p.o.) significantly reduced the serum  
TC, TG, LDL-c, VLDL-c levels but significantly 
increased serum HDL-c level as compared with a 
positive control group (Table 3).  
 
This study showed serum lipid in rats were 
significantly reduced (p < 0.05) by fourteen days 
treatment with Crassocephalum crepidioides at 
dose levels 150 mg/kg and 300 mg/kg, when 
compared with the positive control group. 300 mg 
group animals have shown very significant (p < 
0.01) compared with the positive control group. 
Decrease in the AI was observed in all treated 
groups with Crassocephalum crepidioides and 





Antioxidant activity can be attributed to various 
mechanisms like prevention of chain initiation, 
binding of transition metal ion catalysts, 
decomposition of peroxides, reductive capacity, 
and radical scavenging activity [4]. In the present 
study, four different antioxidant methods for 
evaluation of antioxidant activity have been used. 
Methanol extract of Crassocephalum 
crepidioides produced significant antioxidant 
activity. This can be attributed to the flavonoids  
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Control 83.13 ±0.87 42.93±1.19 66.35 ±1.64 13.27 ±0.33 26.92 ±0.59 0.94 ±0.04 
Positive control 185.89±2.06 35.12±2.59 126.56 ±1.03 25.31 ±0.21 125.46±4.33 4.32 ±0.43 
Atorvastatin 
10 mg/kg 








108.47±4.92*** 40.38±4.10* 105.64 ±2.47** 21.13 ±0.49** 46.96 ±3.95*** 1.70 ±0.25** 
 
Values were expressed as mean ±SD (n=5). Values were statistically significant at *P<0.05 and more significant at **P<0.01, ***P<0.001 
vs positive control using one way ANOVA followed by Dunnet’s test 
 















Control 84.03 ±0.74 42.79 ±1.48 66.41 ±1.59 13.28 ±0.32 27.95 ±2.09 0.96 ±0.08 
Positive 
control 












108.68 ±2.81*** 43.49 ±1.98*** 105.77 ±5.58* 21.15 ±1.12** 44.03 ±5.55*** 1.5 ±0.17** 
 
Values were expressed as mean ± SD (n = 5). Values are statistically significant at *p < 0.05 and more significant at **p < 0.01, ***p < 
0.001 vs positive control using one way ANOVA followed by Dunnet’s test 
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and other phytoconstituents present in the 
extract. 
 
Hyperlipidemia is one of the important risk 
factors involved in the development of 
cardiovascular diseases. Atherosclerosis, 
ischemic heart disease and myocardial infarction 
are strongly associated with disorders of lipid 
metabolism and plasma lipoproteins [32]. It was 
considered that the Triton treated rats were 
useful as an acute hyperlipidemia model 
associated with inactive lipoprotein lipase [33]. 
Triton acts as a surfactant to block the uptake of 
lipoprotein from the circulation [34]. AI is believed 
to be an important risk factor for diagnosis of 
atherosclerosis. The methanol extract of our 
Crassocephalum crepidioides reduced 
atherogenic index, which is one of the most 
important risk factors of atherosclerotic plaques. 
This indicates that Crassocephalum crepidioides 
not only reduces the synthesis of cholesterol, but 
may also reduce its metabolism. The extract 
showed the presence of flavonoids and it is 
reported that flavonoids can inhibit 
hydroxymethylglutaryl-coenzyme A (HMG-CoA) 
reductase activity [33]. However, further studies 




The methanol extract of Crassocephalum 
crepidioides possesses significant antioxidant 
activity as well as promising antihyperlipidemic 
activity. There is, however, need for further 
studies to determine the exact mechanism of 
antihyperlipidemic activity and also to isolate the 
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